These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6794851)

  • 1. Genetics and halothane hepatitis.
    Cousins MJ; Gourlay GK; Hall P; Adams J
    Br Med J (Clin Res Ed); 1981 Nov; 283(6302):1334-5. PubMed ID: 6794851
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of the immunological basis of halothane-induced hepatotoxicity.
    Satoh H; Gillette JR; Takemura T; Ferrans VJ; Jelenich SE; Kenna JG; Neuberger J; Pohl LR
    Adv Exp Med Biol; 1986; 197():657-73. PubMed ID: 3532710
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane.
    Kenna JG; Satoh H; Christ DD; Pohl LR
    J Pharmacol Exp Ther; 1988 Jun; 245(3):1103-9. PubMed ID: 3385639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of sho-saiko-to (xiao-chai-hu-tang) on hepatic injury induced by halothane in rats].
    Mitsukawa H; Ikeda K
    Masui; 1991 May; 40(5):794-800. PubMed ID: 1830118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enzyme histochemical studies on liver damage caused by halothane as compared to diethyl ether and chloroform].
    Hecker D; Meyer M; Lohs K; Wildner G
    Acta Histochem; 1971; 41(2):293-305. PubMed ID: 5004764
    [No Abstract]   [Full Text] [Related]  

  • 6. Respective roles of hypoxia and halothane metabolism in halothane-induced liver injury in rats.
    Gelman S
    Hepatology; 1986; 6(1):156-7. PubMed ID: 3943783
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention by metyrapone of halothane induced liver necrosis in rats (author's transl)].
    Nastainczyk W; Rendic S; Ullrich V; Krüger R
    Anaesthesist; 1982 Apr; 31(4):181-4. PubMed ID: 6807128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the requirements for hepatic injury with halothane and enflurane in rats.
    Lind RC; Gandolfi AJ; Sipes IG; Brown BR
    Anesth Analg; 1985 Oct; 64(10):955-63. PubMed ID: 4037395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential metabolic basis for enflurane hepatitis and the apparent cross-sensitization between enflurane and halothane.
    Christ DD; Satoh H; Kenna JG; Pohl LR
    Drug Metab Dispos; 1988; 16(1):135-40. PubMed ID: 2894942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting the expression of trifluoroacetylated liver microsomal protein neoantigens in rats treated with halothane.
    Kenna JG; Martin JL; Satoh H; Pohl LR
    Drug Metab Dispos; 1990; 18(5):788-93. PubMed ID: 1981738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of changes in antipyrine pharmacokinetics in halothane and paracetamol induced hepatic necrosis in rats.
    Knights KM; Gourlay GK; Hall P; Cousins MJ
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):199-215. PubMed ID: 6878865
    [No Abstract]   [Full Text] [Related]  

  • 12. Halothane hepatitis.
    Lancet; 1978 Oct; 2(8093):790-1. PubMed ID: 80714
    [No Abstract]   [Full Text] [Related]  

  • 13. [Halothane hepatitis].
    Fehér J; Vásárhelyi B; Blázovics A
    Orv Hetil; 1993 Aug; 134(33):1795-8. PubMed ID: 8351144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of halothane, isoflurane, and blood loss on hepatotoxicity and hepatic oxygen availability in phenobarbital-pretreated hypoxic rats.
    Gelman S; Rimerman V; Fowler KC; Bishop SP; Bradley EL
    Anesth Analg; 1984 Nov; 63(11):965-72. PubMed ID: 6496981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoantigens associated with halothane hepatitis.
    Pohl LR; Kenna JG; Satoh H; Christ D; Martin JL
    Drug Metab Rev; 1989; 20(2-4):203-17. PubMed ID: 2680380
    [No Abstract]   [Full Text] [Related]  

  • 16. Late dimethyl sulfoxide administration provides a protective action against chemically induced injury in both the liver and the kidney.
    Lind RC; Gandolfi AJ
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):201-7. PubMed ID: 9007050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrous oxide does not hinder the repair of halothane-induced hepatic injury in the rat.
    Fassoulaki A; Eger EI; Johnson BH; Ferrell LD; Smuckler EA; Cahalan MK; Eger RR; Harper MH
    Anesth Analg; 1985 May; 64(5):465-7. PubMed ID: 3994007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postanesthetic hepatic injury in rats: influence of alterations in hepatic blood flow, surgery, and anesthesia time.
    Harper MH; Collins P; Johnson BH; Eger EI; Biava CG
    Anesth Analg; 1982 Feb; 61(2):79-82. PubMed ID: 7198881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Etiological factors in halothane hepatoxicity].
    Cousins MJ
    Cah Anesthesiol; 1987 Oct; 35(6 Suppl):7-14. PubMed ID: 3676905
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ultrastructure of the hepatocyte in halothane poisoning. Study in rats].
    Cardoso JM; Alcántara G; Castro E; Mravko E
    Rev Invest Clin; 1973; 25(1):9-17. PubMed ID: 4805170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.